HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 31 filers reported holding HORIZON PHARMA INVT LTD in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $13,225,000 | +3543.3% | 11,500,000 | +4081.8% | 0.01% | – |
| Q4 2019 | $363,000 | -95.5% | 275,000 | -96.6% | 0.00% | -100.0% |
| Q3 2018 | $8,047,000 | +5.1% | 8,000,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $7,656,000 | +87.6% | 8,000,000 | +79.7% | 0.00% | 0.0% |
| Q1 2018 | $4,081,000 | +192.5% | 4,451,000 | +196.5% | 0.00% | +100.0% |
| Q4 2017 | $1,395,000 | +93.2% | 1,501,000 | +87.6% | 0.00% | – |
| Q3 2017 | $722,000 | -78.0% | 800,000 | -79.0% | 0.00% | -100.0% |
| Q2 2017 | $3,281,000 | -6.0% | 3,807,000 | -0.8% | 0.00% | -33.3% |
| Q1 2017 | $3,490,000 | +15.6% | 3,836,000 | +20.8% | 0.00% | +50.0% |
| Q4 2016 | $3,019,000 | +41.9% | 3,175,000 | +44.3% | 0.00% | 0.0% |
| Q3 2016 | $2,127,000 | +6.7% | 2,200,000 | -0.1% | 0.00% | +100.0% |
| Q2 2016 | $1,994,000 | +202.1% | 2,202,000 | +184.1% | 0.00% | – |
| Q1 2016 | $660,000 | – | 775,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 144,832,000 | $191,529,000 | 6.11% |
| SYMPHONY ASSET MANAGEMENT LLC | 10,000,000 | $13,256,000 | 2.93% |
| Nicholas Investment Partners, LP | 4,380,000 | $5,784,000 | 0.60% |
| Sonora Investment Management, LLC | 4,725,000 | $6,258,000 | 0.59% |
| CSS LLC/IL | 7,836,000 | $10,420,000 | 0.58% |
| SSI INVESTMENT MANAGEMENT LLC | 6,397,000 | $8,448,000 | 0.56% |
| Shaolin Capital Management LLC | 2,500,000 | $3,323,000 | 0.54% |
| MIZUHO SECURITIES USA LLC | 5,000,000 | $6,635,000 | 0.33% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 8,846,000 | $11,766,000 | 0.23% |
| M&G INVESTMENT MANAGEMENT LTD | 19,210,000 | $25,357,000 | 0.22% |